View in EDS HTML Full Text PDF Full Text

Assessing the Pharmacological and Pharmacogenomic Data of PD-1/PD-L1 Inhibitors to Enhance Cancer Immunotherapy Outcomes in the Clinical Setting.

Saved in:
Bibliographic Details
Title: Assessing the Pharmacological and Pharmacogenomic Data of PD-1/PD-L1 Inhibitors to Enhance Cancer Immunotherapy Outcomes in the Clinical Setting.
Authors: Zervanos, Damianos-Ioannis1 (AUTHOR), Galatou, Eleftheria2 (AUTHOR), Miliotou, Androulla N.1,2 (AUTHOR), Theodoroula, Nikoleta F.1,2 (AUTHOR), Grigoriadis, Nikolaos1 (AUTHOR), Vizirianakis, Ioannis S.1,2 (AUTHOR)
Source: Future Pharmacology. Sep2025, Vol. 5 Issue 3, p43. 42p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:26739879
DOI:10.3390/futurepharmacol5030043